B

BioVaxys Technology
BIOV

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CA$11.74M
EV
CA$11.65M
Shares Outstanding
293.43M
Beta
-0.14

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BioVaxys Technology Corp.

gainify

B

BioVaxys Technology Corp.

BIOV

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics. The company offers DPX immune-educating technology platform and HapTenix neoantigen tumor cell construct platform for ...

Sector

Healthcare

Industry

Biotechnology

CEO

Passin, James

Employees

IPO Date

2018-11-27

Headquarters

146 Thirtieth Street, Suite 100, Etobicoke, Ontario, M8W 3D4, Canada

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved